How to Develop Robust Solid Oral Dosage Forms

How to Develop Robust Solid Oral Dosage Forms : From Conception to Post-Approval

By (author) 

Free delivery worldwide

Available. Dispatched from the UK in 1 business day
When will my order arrive?

Description

How to Develop Robust Solid Oral Dosage Forms from Conception to Post-Approval uses a practical and hands-on approach to cover the development process of solid oral dosage forms in one single source. The book details all of the necessary steps from formulation through the post-approval phase and contains industry case studies, real world advice, and troubleshooting tips.

By merging the latest scientific information with practical instructions, this book provides pharmaceutical scientists in formulation research and development with a concrete look at the key aspects in the development of solid oral dosage forms.
show more

Product details

  • Paperback | 190 pages
  • 152 x 229 x 12.7mm | 320g
  • Academic Press Inc
  • San Diego, United States
  • English
  • 0128047313
  • 9780128047316

Table of contents

Chapter 1. Rules of Drug Product Development

Chapter 2. Pharmacokinetics and Preformulation

Chapter 3. Formulation Development

Chapter 4. Pharmaceutical Unit Operations

Chapter 5. Process Development

Chapter 6. Analytical Considerations

Chapter 7. Process Scale-up, Tech-Transfer, and Optimization

Chapter 8. Business Acuity
show more

About Bhavishya Mittal

Bhavishya Mittal is a Staff Fellow at the Office of Pharmaceutical Quality at the US Food and Drug Administration (FDA) in Silver Spring, MD. Previously, Bhavi was employed as a Senior Scientist in the Formulation Sciences department at Takeda Pharmaceuticals International Company based in Cambridge, MA. Bhavi has a PhD in Materials Engineering from the Pennsylvania State University and a BS in Chemical Engineering from Regional Engineering College, Jalandhar (India). Bhavi has 13 years of industrial experience in formulation and process development of various solid oral dosages of small therapeutic molecules (oncology, inflammation, and CNS indications) aimed for NDA and ANDA filings. He is the co-chair of the Formulation and Drug Delivery (FDD) working group at MassBio. He is the author/co-author of 1 patent, 10 peer-reviewed manuscripts, and numerous conference papers and posters published/presented in various international journals and conferences. He is an active member of various international professional societies such as AAPS and ISPE. His research interests include formulation design, process engineering, scale-up and tech-transfer, and computational modeling of pharmaceutical unit operations for solid oral dosage manufacturing.
show more